Industry Symposium 9


13:30-15:00    Room N10

Novel iron-containing phosphate binder
The value added

Chairs: John Cunningham, London, UK
             Jordi Bover, Barcelona, Spain

Why was it necessary to invent sucroferric oxyhydroxide?
David Goldsmith, London, UK
Phosphate binding is the name of the game – playing strong in the CKD-MBD field
Jürgen Floege, Aachen, Germany
Dialysis Patients in focus - Potential added benefits
Stuart Sprague, Evanston, USA

Organised by VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA


back to the timetable